Turnaround time
10 workdays
48.4
40
Genetic test for the LAMA2 c.3285G>A variant that causes congenital muscular dystrophy (CMD/MD) in Italian Greyhounds.
Overview
This genetic test assesses the LAMA2 c.3285G>A variant that causes congenital muscular dystrophy in Italian Greyhounds. The condition is also referred to as CMD, congenital muscular dystrophy, MD or LAMA2-related muscular disease.
Affected dogs usually develop clear muscle problems early in life. Typical features include poor growth, generalized muscle atrophy, a stiff or short-strided gait, exercise intolerance, weakness and sometimes regurgitation or poor body condition.
Included subanalyses
This analysis includes the following subanalysis:
Allele combinations & result interpretations
Below, for each tested locus, you will find the possible allele combinations that may be reported within this analysis, together with a brief explanation of their genetic meaning. The interpretation of possible interactions between different loci is included in the report, but is not shown here in full because that would lead to too many combinations on this page. The final expression may also depend on other genes and their interaction.
Genotype / allele combination: Clear (GG)
No copies of the tested LAMA2 variant were detected. This dog will not develop LAMA2-related CMD from this variant and will not pass this variant to offspring.
Genotype / allele combination: Carrier (GA)
One copy of the tested LAMA2 variant was detected. This dog is a carrier: it will not develop CMD from this recessive variant itself, but can pass the variant to about half of its offspring.
Genotype / allele combination: Affected (AA)
Two copies of the tested LAMA2 variant were detected. This genotype causes LAMA2-related congenital muscular dystrophy in Italian Greyhounds and explains a high risk of severe muscle weakness, muscle wasting and mobility problems.
Sampling and submission guidelines





References